KNKateryna Nesteruk

Kateryna Nesteruk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kateryna Nesteruk has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Anouk van de Winkel

    Department of Gastroenterology and Hepatology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands

    1 shared publication
  • Auke P. Verhaar

    Department of Gastroenterology and Hepatology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands

    1 shared publication
  • Bingting Yu

    Department of Gastroenterology and Hepatology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands

    1 shared publication
  • Ernst J. Kuipers

    Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands

    1 shared publication
  • Gwenny M. Fuhler

    Department of Gastroenterology and Hepatology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands

    1 shared publication
  • H. Scott Stadler

    Department of Skeletal Biology, Shriners Hospital for Children, Portland, USA

    1 shared publication

Latest Publications

  • Open Access

    HOXA13 in etiology and oncogenic potential of Barrett’s esophagus

    by Vincent T. Janmaat, Kateryna Nesteruk, Manon C. W. Spaander, Auke P. Verhaar, Bingting Yu, Rodrigo A. Silva, Wayne A. Phillips, Marcin Magierowski, Anouk van de Winkel, H. Scott Stadler, et al.

    Barrett’s esophagus in gastrointestinal reflux patients constitutes a columnar epithelium with distal characteristics, prone to progress to esophageal adenocarcinoma.HOXgenes are known mediators of position-dependent morphology. Here we showHOXcollinearity in the adult gut while Barrett’s esophagus shows highHOXA13expression in stem cells and their progeny.HOXA13overexpression appears sufficient to explain both the phenotype (through downregulation of the epidermal differentiation complex) and the oncogenic potential of Barrett’s esophagus. Intriguingly, employing a mouse model that contains a reporter coupled to theHOXA13promotor we identify single HOXA13-positive cells distally from the physiological esophagus, which is mirrored in human physiology, but increased in Barrett’s esophagus. Additionally, we observe thatHOXA13expression confers a competitive advantage to cells. We thus propose that Barrett’s esophagus and associated esophageal adenocarcinoma is the consequence of expansion of this gastro-esophagealHOXA13-expressing compartment following epithelial injury.